Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease

Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice

NCT02172495 ·Status: COMPLETED

Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172482 ·Status: COMPLETED

Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

NCT04780984 ·Status: COMPLETED ·Phase: PHASE2

Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients

NCT00157235 ·Status: COMPLETED ·Phase: PHASE3

Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea

NCT00540163 ·Status: COMPLETED

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02175342 ·Status: COMPLETED ·Phase: PHASE2

Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation

NCT02172508 ·Status: TERMINATED ·Phase: PHASE4

A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

NCT02275481 ·Status: TERMINATED ·Phase: PHASE4

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers

NCT02259959 ·Status: COMPLETED ·Phase: PHASE1

Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

NCT00274027 ·Status: COMPLETED ·Phase: PHASE3

Tiotropium (Spiriva) Rehabilitation Study

NCT00274521 ·Status: COMPLETED ·Phase: PHASE3

Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

NCT02172521 ·Status: COMPLETED

Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

NCT00274508 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice

NCT00624377 ·Status: COMPLETED

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT05986591 ·Status: COMPLETED ·Phase: PHASE3

SPIRIVA in Ususal Care

NCT00274079 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence Study of Tiotropium Bromide Inhalation Powder

NCT05161156 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma

NCT00152984 ·Status: COMPLETED ·Phase: PHASE4

Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders

NCT00274014 ·Status: COMPLETED ·Phase: PHASE3

Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema

NCT00570544 ·Status: COMPLETED

Tiotropium Bromide in Cystic Fibrosis

NCT01179347 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example

NCT01036763 ·Status: COMPLETED

Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients

NCT01119937 ·Status: COMPLETED ·Phase: PHASE3

Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities

NCT00621582 ·Status: COMPLETED

Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease

NCT02850978 ·Status: COMPLETED